Fibrinogen Deposition without Thrombin Generation in Primary Human Breast Cancer Tissue

Cancer Research

Volumn 51, Issue 1, 1991, Pages 349-353

  Zacharski, Leo R ^a,c,c   Rousseau, Sandra M ^c  

^a Departments of Mediane and Pathology ^*  (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e NEW YORK BLOOD CENTER   (United States)

^f UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; FIBRINOGEN; THROMBIN; THROMBOMODULIN;

ARTICLE; BLOOD CLOTTING; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FACTOR VII; FACTOR X; FIBRIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOENZYME TECHNIQUES; IN VITRO; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THROMBIN; TRANSGLUTAMINASES;

EID: 0026034135     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Harris, J. R., Canellos, G. P., Hellman, S., and Fisher, B. Cancer of the breast. In: V. T. De Vita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer, Principles and Practice of Oncology, Ed. 2, pp. 1119-1177. Philadelphia: J.B. Lippincott Co., 1985.
2. Dvorak, R. F. Thrombosis and cancer. Hum. Pathol., 18:275-284, 1987.
3. Zacharski, L. R., Henderson, W. G., Rickles, F. R., Forman, W. B., Cornell, C. J., Jr., Forcier, R. J., Headley, E., Kim, S-H., O'Donnell, J. F., O'Dell, R., Tornyos, K., and Kwaan, H. C. Effect of sodium warfarin on survival in small cell carcinoma of the lung. J. Am. Med. Assoc., 245:831-835, 1981.
4. Chahinian, A. P., Propert, K. J., Ware, J. H., Zimmer, B., Perry, M. C., Hirsh, V., Skarin, A., Kopel, S., Holland, J. F., Comis, R. L., and Green, M. R. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J. Clin. Oncol., 7:993-1002, 1989.
5. Zacharski, L. R., Cornell, C. J., Haakenson, C. M., Ballard, H. S., Crum, E. D., Johnson, G. J., Levine, J., Hong, W. K., O'Donnell, J. F., Schilsky, R. L., Ringenberg, Q. S., Robert, F., Spaulding, M. B., Tornyos, K., William, C., and Zucker, S. Effect of RA-233 (Mopidamole) on survival in carcinoma of the lung and colon. Final report of VA Cooperative Study 188. J. Natl. Cancer Inst., 80:9097-9141, 1988.
6. Schneider, B., Geser, C., and Feuerer, W. Effect of anticoagulation treatment with RA-233 (Mopidamole) on survival in bronchial cancer. Thromb. Haemost., 58: 508, 1987.
7. Zacharski, L. R., Henderson, W. G., Rickles, F. R., Forman, W. B., Cornell, C. J., Jr., Forcier, R. J., Edwards, R. I., Headley, E., Kim, S-H., O'Donnell, J. F., O'Dell, R., Tornyos, K., and Kwaan, H. C. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study 75. Cancer (Phila.), 53: 2046-2052, 1984.
8. Zacharski, L. R., and Donati, M. B. Registry of clinical trials of antithrombotic drugs in cancer. Thromb. Haemost., 61:526-528, 1989.
9. Zacharski, L. R., Memoli, V. A., Rousseau, S. M., and Kisiel, W. Coagulation-cancer interaction in situ in small cell carcinoma of the lung. Cancer (Phila.), 60:2675-2681,1987.
10. Zacharski, L. R., Memoli, V. A., and Rousseau, S. M. Thrombin-specific sites of fibrinogen in small cell carcinoma of the lung. Cancer (Phila.), 62: 299-302, 1988.
11. Wojtukiewicz, M. Z., Zacharski, L. R., Memoli, V. A., Kisiel, W., Kudryk, B. J., Rousseau, S. M., and Stump, D. C. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer (Phila.), 65: 481-485, 1990.
12. Zacharski, L. R., Memoli, V. A., and Rousseau, S. M. Cancer-coagulation interaction in situ in renal cell carcinoma. Blood, 68: 394-399, 1986.
13. Wojtukiewicz, M. Z., Zacharski, L. R., Memoli, V. A., Kisiel, W., Kudryk, B. J., Rousseau, S. M., and Stump, D. C. Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Res., 10: 579-582, 1990.
14. Wojtukiewicz, M. Z., Zacharski, L. R., Memoli, V. A., Kisiel, W., Kudryk, B. J., Rousseau, S. M., and Stump, D. C. Indirect activation of blood coagulation in colon cancer. Thromb. Haemost., 62: 1062-1066, 1989.
15. Wojtukiewicz, M. Z., Zacharski, L. R., Memoli, V. A., Kisiel, W., Kudryk, B. J., Rousseau, S. M., and Stump, D. C. Absence of components of coagulation and fibrinolysis pathways in situ in mesothelioma. Thromb. Res., 55: 279-284, 1989.
16. Cozzolino, F., Torcia, M., Miliani, A., Carossino, A. M., Giordani, R., Cinotti, S., Filimberti, E., Saccardi, R., Bemabei, P., Guidi, G., DiGuglielmo, R., Pistoia, V., Ferrarini, M., Nawroth, P. P., and Stem, D. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphocytic leukemia. Am. J. Med., 84: 240-250, 1988.
17. McCulloch, P., Douglas, J., Lowe, G. D. O., Murray, G., and George, W. D. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer. Thromb. Haemost., 61: 318-321, 1989.
18. Gore, J. M., Appelbaum, J. S., Greene, H. L., Dexter, L., and Dalen, J. E. Occult cancer in patients with acute pulmonary embolism. Ann. Intern. Med., 96: 556-560, 1982.
19. Feffer, S. E., Carmosino, L. S., and Fox, R. L. Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer (Phila.), 63: 1303-1307,1989.
20. Rogers, J. S., II, Murgo, A. J., Fontana, J. A., and Raich, P. C. Chemotherapy for breast cancer decreases plasma protein C and protein S. J. Clin. Oncol., 6: 276-281, 1988.
21. Dvorak, H. F., Senger, D. R., and Dvorak, A. M. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metastasis Rev., 2:41-73, 1983.
22. Sato, Y., Mukai, K., Watanabe, S., Goto, M., and Shimosato, Y. The AMeX method. Am. J. Pathol., 125:431-435, 1986.
23. Zacharski, L. R., Schned, A., and Sorenson, G. D. Occurrence of fibrin and tissue factor antigen in small cell carcinoma of the lung. Cancer Res., 43: 3963-3968, 1982.
24. Lechago, J., Sun, N. C. J., and Weinstein, W. M. Simultaneous visualization of two antigens in the same tissue section by combining immunoperoxidase with immunofluorescence techniques. J. Histochem. Cytochem., 27: 12211225, 1979.
25. Mason, D. Y., Abdulaziz, Z., Falini, B., and Stein, H. Double immunoenzymatic labelling. In: J. M. Polak and S. Van Noorden (eds.), Immunohisto-chemistry. Practical Applications in Pathology, pp. 113-128. Littleton, MA: John Wright PSG Inc., 1983.
26. Kudryk, B., Rohoza, A., Ahadi, M., Chin, J., and Wiebe, M. E. Specificity of a monoclonal antibody for the NH2-terminal fragments derived from fibrinogen and fibrin. Mol. Immunol., 20:1191-1200, 1983.
27. Kudryk, B., Rohoza, A., Ahadi, M., Chin, J., and Wiebe, M. E. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol. Immunol., 21:89-94, 1984.
28. Kudryk, B., Grossman, Z. D., McAfee, J. G., and Rosebrough, S. F. Monoclonal antibodies as probes for fibrin(ogen) proteolysis. In: J. F. Chatal (ed.), Monoclonal Antibodies in Immunoscintigraphy, pp. 365-398. Boca Raton, FL: CRC Press, 1989.
29. Bini, A., Mesa-Tejada, R., Fenoglio, J. J., Jr., Kudrvk, B., and Kaplan, K. L. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies. Lab. Invest., 60:814-821,1989.
30. Mitchell, W. H., Parson, B. J., and Althous, J. Coagulation problems in patients with cancer. J. Surg. Oncol., 13:323-327, 1980.
31. Mannucci, P. M., Cugno, M., Mameli, G., Marongiu, F., and Bianchi Bonomi, A. Fibrin(ogen) peptides in early breast cancer. Thromb. Haemost., 62:8-19, 1989.
32. Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., McDonagh, J., and Dvorak, A. M. Fibrin containing gells induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest., 57: 673-686, 1987.
33. Dvorak, H. F., Dickersin, G. R., Dvorak, A. M., Manseau, E. J., and Pyne, K. Human breast carcinoma: fibrin deposits and desmoplasia, inflammatory cell type and distribution, microvasculature and infarction. J. Natl. Cancer Inst., 67: 335-345, 1981.
34. Dvorak, H. F., Orenstein, N. S., and Dvorak, A. M. Tumor-secreted mediators and the tumor microenvironment: relationship to immunological surveillance. Lymphokines, 2: 208-233, 1981.
35. Dvorak, H. F., Senger, D. R., Dvorak, A. M., Harvey, V. S., and McDonagh, J. Regulation of extravascular coagulation by microvascular permeability. Science (Washington DC), 227: 1059-1061, 1985.
36. Grignani, G., Pacchiarini, L., Ricetti, M. M., Dionigi, P., Jemos, V., Zuc-chella, M., and Fratino, P. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues. Invasion Metastasis, 9: 298-309, 1989.
37. Eche, N., Sie, P., Jozan, S., Courriere, P., and David, J. F. Platelet aggregating and procoagulant activities of cultured human breast cancer cells (FAM). Thromb. Res., 43: 121-127, 1986.
38. Blomback, B., Procyk, R., Adamson, L., Hessel, B. F XIII induced gelation of human fibrinogen-an alternative thiol enhanced, thrombin independent pathway. Thromb. Res., 37:613-627, 1985.
39. Procyk, R., Adamson, L., Block, M., and Blomback, B. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers-a thiol enhanced process. Thromb. Res., 140: 833-852, 1985.
40. Grinnel, F., Feld, M., and Minter, D. Fibroblast adhesion to fibrinogen and fibrin substrata; requirement for cold-insoluble globulin (plasma flbronectin). Cell, 19:517, 1980.
41. Grignani, G., Falanga, A., Pacchiarini, L., Alesso, M. G., Zuchella, M., Fratino, P., and Donati, M. B. Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties. Int. J. Cancer, 42: 554-557, 1988.
42. Esmon, N. L. Thrombomodulin. Prog. Hemost. Thromb., 9: 29-55, 1989.
43. Yonezawa, S., Maruyama, I., Tanaka, S., Nakamura, T., and Sato, E. Immunohistochemical localization of thrombomodulin in chronic diseases of the uterus and choriocarcinoma of the stomach. Cancer (Phila.), 62:569-576, 1988.
44. Yonezawa, S., Maruyama, I., Sakae, K., Igata, A., Majerus, P. W., and Sato, E. Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europeus I lectin. Am. J. Clin. Pathol., 88: 405-411, 1987.
45. Thornes, R. D. Oral anticoagulant therapy of human cancer. J. Med., 5:83-91, 1974.
46. Sagripanti, A., Carpi, A., Baicchi, U., Nicolini, A., and Grassi, B. Oral anticoagulants in the adjuvant therapy of breast cancer three years experience. Thromb. Haemost., 62: 137, 1989.